With the advent of minimally invasive approaches, liver surgery has changed significantly. The ongoing search for new organ-sparing treatments has produced approaches that combine interventional techniques with open surgery,
endoscopy, and procedures requiring robotic assistance. As a result, liver surgeons increasingly need to coordinate imaging, intervention, and surgery – all in one room.
Our imaging systems with procedural intelligence allow you to integrate new therapeutic options in the Hybrid OR. From liver embolization, to endoscopic treatments, to ablation and resection, every possible approach or combination
can now be performed in your Hybrid OR, with the hospital’s resources centered around the patient. Sophisticated planning and guidance enables you treat many more patients with curative intent, increasing their survival from months to years.
Abdominal procedures with Hybrid OR imaging solutions
In liver cancer therapy, Hybrid OR imaging solutions boost surgical precision, help eliminate anatomical guesswork, and make high-end techniques available to more patients.
Stereotactic radio frequency ablation (SRFA)
Ablation is a promising approach to curatively treat various types of liver cancer. Our imaging systems offer the sophisticated 3D planning and guidance needed to achieve multiple overlapping necroses, supporting surgeons in ablating tumors larger than 5 cm. Intraprocedural assessment makes sure margins are complete.
Image-guided Laparoscopic Liver Surgery (ILLS)
Liver resection is the gold standard for radical treatment of liver metastases and in many cases the main treatment of primary tumors. Making full use of our imaging systems, the new ILLS technique maximizes the amount of healthy liver left behind
while ensuring adequate oncological margins. This potentially increases the number of patients who can be resected.
Success story: Experts’ meeting in Strasbourg
At Siemens Healthineers, we believe that our relationship with customers must go beyond providing cutting-edge technology, particularly in new fields. Image-guided therapies for liver cancer are in the early stages of their development, and their advancement requires close collaboration between surgeons and interventional radiologists, for the benefit of all patients.
To bring together experts from leading institutions around the world, we created a working group that meets annually to share know-how and experiences. In 2019, this meeting took place at IHU Strasbourg. We asked some participants how they see the future of liver therapies, as well as how image guidance can support that evolution.
Interview at IHU Strasbourg
The statements with footnotes in this document are based on a result of the quoted clinical study that evaluates the procedure. The results are not generated with the actual product version. It is expected, that the actual product version has similar or improved
functionality to support the evaluated procedure.
Some/All of the features and products described herein may not be available in the United States or other countries.
1Reto Bale et al., “Stereotactic radiofrequency ablation of hepatocellular carcinoma – A histopathological study in explanted livers,” Hepatology (2018): 1–11, https://doi.org/10.1002/hep.30406.
2Stereotactic Radiofrequency Ablation (SRFA) means using a 3D coordinate system within the 3D image, to place the ablation needles in a specific position to create overlapping ablation areas, to help ensure tumor coverage.